No Prescription |
 |
 | ||
|
Naramig Amerge |
|
| ||
No Prescription » Prescription Drugs 11 » Naramig Amerge Product Origin: EU (Turkey)This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English.Medical Information:Naratriptan Tablets should not be given to patients with history symptoms or signs of ischemic cardiac cerebrovascular or peripheral vascular syndromes. In addition patients with other significant underlying cardiovascular diseases should not receive Naratriptan Tablets. Ischemic cardiac syndromes include but are not limited to angina pectoris of any type (e. g. stable angina of effort and vasospastic forms of angina such as the Prinzmetal's variant) all forms of myocardial infarction and silent myocardial ischemia. Cerebrovascular syndromes include but are not limited to strokes of any type as well as transient ischemic attacks. Peripheral vascular disease includes but is not limited to ischemic bowel disease. Because Naratriptan Tablets may increase blood pressure they should not be given to patients with uncontrolled hypertension Naratriptan Tablets are contraindicated in patients with severe renal impairment (creatinine clearance <15 mL/ min) Naratriptan Tablets are contraindicated in patients with severe hepatic impairment (Child-Pugh grade C) Naratriptan Tablets should not be administered to patients with hemiplegic or basilar migraine. Naratriptan Tablets should not be used within 24 hours of treatment with another 5-HT1 agonist an ergotamine-containing or ergot-type medication like dihydroergotamine or methysergide. Naratriptan Tablets are contraindicated in patients with hypersensitivity to naratriptan or any of the components. Buy Naramig Amerge and other Prescription Drugs 11 products online at Medstore. 3693
About Naramig Amerge: Product Type: Prescription Drugs 11 Naramig ( Amerge Generic Naratriptan ) Naramig (Amerge Generic Naratriptan) Amerge Generic Naratriptan 2.5mg 2 Tablets Amerge Generic Naratriptan Naramig
View more Prescription Drugs 11 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
